Home > National Drug Code (NDC) > Trandolapril and Verapamil Hydrochloride

Trandolapril and Verapamil Hydrochloride - 68462-295-90 - (Trandolapril and Verapamil Hydrochloride)

Alphabetical Index


Drug Information of Trandolapril and Verapamil Hydrochloride

Product NDC: 68462-295
Proprietary Name: Trandolapril and Verapamil Hydrochloride
Non Proprietary Name: Trandolapril and Verapamil Hydrochloride
Active Ingredient(s): 2; 180    mg/1; mg/1 & nbsp;   Trandolapril and Verapamil Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Trandolapril and Verapamil Hydrochloride

Product NDC: 68462-295
Labeler Name: Glenmark Generics Inc., USA
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA079135
Marketing Category: ANDA
Start Marketing Date: 20100526

Package Information of Trandolapril and Verapamil Hydrochloride

Package NDC: 68462-295-90
Package Description: 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-90)

NDC Information of Trandolapril and Verapamil Hydrochloride

NDC Code 68462-295-90
Proprietary Name Trandolapril and Verapamil Hydrochloride
Package Description 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-90)
Product NDC 68462-295
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Trandolapril and Verapamil Hydrochloride
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20100526
Marketing Category Name ANDA
Labeler Name Glenmark Generics Inc., USA
Substance Name TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
Strength Number 2; 180
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC]

Complete Information of Trandolapril and Verapamil Hydrochloride


General Information